Skip to main content
Equibles

Kristine Ball

Board Member

Enliven Therapeutics, Inc. (ELVN)

Equibles does not estimate personal net worth.

About Kristine Ball

Kristine Ball is recorded as Board Member at Enliven Therapeutics, Inc. (ELVN) since October 14, 2026. Enliven Therapeutics, Inc. reported in an 8-K filed October 14, 2026 that Kristine Ball was appointed Class II director, effective October 14, 2026. Enliven Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enliven Therapeutics, Inc. includes Richard Fair (CEO and Board Member), Rick Fair (CEO and Board Member), Sam Kintz, M.B.A. (CEO and Board Member) and 7 others.

“On October 14, 2026, the board of directors (the "Board") of Enliven Therapeutics, Inc. (the "Company") increased the size of the Board from seven to eight directors and appointed Kristine Ball to serve as a Class II director, with a term expiring at the Company's 2028 annual meeting of stockholders, and as a member of the Audit Committee of the Board (the "Audit Committee"), effective October 14, 2026.”
Enliven Therapeutics, Inc. Form 8-K, filed October 14, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Enliven Therapeutics, Inc.

Recent activity